|
[1]HAO W, CHEN H, SU Z.China:alcohol today[J].Addiction, 2005, 100 (6) :737-741.
|
|
[2]LOMBARDI R, BUZZETTI E, ROCCARINA D, et al.Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease[J].World J Gastroenterol, 2015, 21 (39) :11044-11052.
|
|
[3]CHROSTEK L, PANASIUK A.Liver fibrosis markers in alcoholic liver disease[J].World J Gastroenterol, 2014, 20 (25) :8018-8023.
|
|
[4]SORBI D, BOYNTON J, LINDOR KD.The ratio of aspartate aminotransferase to alanine aminotransferase:potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease[J].Am J Gastroenterol, 1999, 94 (4) :1018-1022.
|
|
[5]WANG J, LI P, JIANG Z, et al.Diagnostic value of alcoholic liver disease (ALD) /nonalcoholic fatty liver disease (NAFLD) index combined withγ-glutamyl transferase in differentiating ALD and NAFLD[J].Korean J Intern Med, 2016, 31 (3) :479-487.
|
|
[6]LITTEN RZ, BRADLEY AM, MOSS HB.Alcohol biomarkers in applied settings:recent advances and future research opportunities[J].Alcohol Clin Exp Res, 2010, 34 (6) :955-967.
|
|
[7]SUEYOSHI S, SAWAI S, SATOH M, et al.Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease[J].World J Hepatol, 2016, 8 (36) :1610-1616.
|
|
[8]GOUGH G, HEATHERS L, PUCKETT D, et al.The utility of commonly used laboratory tests to screen for excessive alcohol use in clinical practice[J].Alcohol Clin Exp Res, 2015, 39 (8) :1493-1500.
|
|
[9]NIEMELAO.Biomarkers in alcoholism[J].Clin Chim Acta, 2007, 377 (1-2) :39-49.
|
|
[10]KOIVISTO H, HIETALA J, NIEMELAO.An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease[J].Am J Gastroenterol, 2007, 102 (4) :773-779.
|
|
[11]CAI WM, ZHANG BB, WENG HL, et al.The diagnostic value of eight serum indices for liver fibrosis[J].Chin J Hepatol, 2004, 12 (4) :219-222. (in Chinese) 蔡卫民, 张彬彬, 翁红雷, 等.八项肝纤维化血清标志物比较研究[J].中华肝脏病杂志, 2004, 12 (4) :219-222.
|
|
[12]SOWA JP, ATMACAO, KAHRAMAN A, et al.Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling[J].PLo S One, 2014, 9 (7) :e101444.
|
|
[13]STICKEL F, POESCHL G, SCHUPPAN D, et al.Serum hyaluronate correlates with histological progression in alcoholic liver disease[J].Eur J Gastroenterol Hepatol, 2003, 15 (9) :945-950.
|
|
[14]LIU T, WANG X, KARSDAL MA, et al.Molecular serum markers of liver fibrosis[J].Biomark Insights, 2012, 7:105-117.
|
|
[15]NØJGAARD C, JOHANSEN JS, CHRISTENSEN E, et al.Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease[J].J Hepatol, 2003, 39 (2) :179-186.
|
|
[16]SCHIAVON LL, CARVALHO-FILHO RJ, NARCISO-SCHIAVON JL, et al.YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection[J].Scand J Gastroenterol, 2010, 45 (5) :615-622.
|
|
[17]WEI H, LI B, ZHANG R, et al.Serum GP73, a marker for evaluating progression in patients with chronic HBV infections[J].PLo S One, 2013, 8 (2) :e53862.
|
|
[18]XU Z, LIU L, PAN X, et al.Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J].Medicine (Baltimore) , 2015, 94 (12) :e659.
|
|
[19]FENG ZG, CEN XH, YUN JM, et al.Diagnostic value of GP73 in alcoholic liver disease[J].Int J Lab Med, 2015, 36 (15) :2214-2215, 2217. (in Chinese) 冯志刚, 岑晓红, 云俊木, 等.GP73在酒精性肝病中的临床意义[J].国际检验医学杂志, 2015, 36 (15) :2214-2215, 2217.
|
|
[20]TOSHIMA T, SHIRABE K, IKEGAMI T, et al.A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA (+) -M2BP) , for assessing liver fibrosis[J].J Gastroenterol, 2015, 50 (1) :76-84.
|
|
[21]ZHOU D, WANG Y, ZHANG W, et al.WFA (+) -M2BP:a novel biomarker with diagnostic and therapeutic implications in liver diseases[J].Liver Int, 2016, 36 (4) :612.
|
|
[22]ZOU X, ZHU MY, YU DM, et al.Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection[J].Liver Int, 2017, 37 (1) :35-44.
|
|
[23]YANG YL, CUI YY, HU Y, et al.Role of the Mac-2 binding protein glycosylation isomer in diagnosis of chronic liver diseases[J].J Clin Hepatol, 2016, 32 (12) :2395-2398. (in Chinese) 杨以良, 崔园园, 胡月, 等.Mac-2结合蛋白糖基化异构体在慢性肝病诊断中的作用[J].临床肝胆病杂志, 2016, 32 (12) :2395-2398.
|
|
[24]HU GW.Research progress of serological detection index for liver fibrosis[J].Infect Dis Info, 2016, 29 (5) :315-317. (in Chinese) 胡高娃.肝纤维化血清学检测指标的研究进展[J].传染病信息, 2016, 29 (5) :315-317.
|
|
[25]CASTERA L.Hepatitis B:are non-invasive markers of liver fibrosis reliable?[J].Liver Int, 2014, 34 (Suppl 1) :91-96.
|
|
[26]NAVEAU S, RAYNARD B, RATZIU V, et al.Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease[J].Clin Gastroenterol Hepatol, 2005, 3 (2) :167-174.
|
|
[27]PARK MS, KIM SU, KIM BK, et al.Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B[J].Liver Int, 2015, 35 (2) :455-462.
|
|
[28]VOICAN CS, LOUVET A, TRABUT JB, et al.Transient elastography alone and in combination with Fibro Testfor the diagnosis of hepatic fibrosis in alcoholic liver disease[J].Liver Int, 2017, 37 (11) :1697-1705.
|
|
[29]CALES P, OBERTI F, MICHALAK S, et al.A novel panel of blood markers to assess the degree of liver fibrosis[J].Hepatology, 2005, 42 (6) :1373-1381.
|
|
[30]LOONG TC, WEI JL, LEUNG JC, et al.Application of the combined Fibro Meter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol, 2017, 32 (7) :1363-1369.
|
|
[31]TIAN HJ.Research progress in serological testing indicators of clinical examination for liver fibrosis[J].China Modern Med, 2013, 20 (9) :26-27. (in Chinese) 田红娟.肝纤维化血清学检测指标的研究进展[J].中国当代医药, 2013, 20 (9) :26-27.
|
DownLoad: